Market entry and exit by biotech and device companies funded by venture capital.
about
Pediatric critical care: grand challenges for a glowing future.Bottlenecks to clinical translation of direct brain-computer interfaces.Multilevel research and the challenges of implementing genomic medicine.The ethics of intellectual property rights in an era of globalization.Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticals.Endovascular repair of aortic disease: a venture capital perspective
P2860
Market entry and exit by biotech and device companies funded by venture capital.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Market entry and exit by biotech and device companies funded by venture capital.
@en
Market entry and exit by biotech and device companies funded by venture capital.
@nl
type
label
Market entry and exit by biotech and device companies funded by venture capital.
@en
Market entry and exit by biotech and device companies funded by venture capital.
@nl
prefLabel
Market entry and exit by biotech and device companies funded by venture capital.
@en
Market entry and exit by biotech and device companies funded by venture capital.
@nl
P2093
P356
P1433
P1476
Market entry and exit by biotech and device companies funded by venture capital.
@en
P2093
Charles A Robinson
Lawton R Burns
Michael G Housman
P304
P356
10.1377/HLTHAFF.28.1.W76
P407
P577
2008-12-02T00:00:00Z